Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

515 ARTÍCULOS , VIENDO DEL 1 AL 15

Neuropsychiatric Manifestations in Alzheimer's Disease Patients: Genetics and Treatment Options

Singh AK, Malviya R, Prakash A, Verma S.

CNS Neurol Disord Drug Targets. 2024;23(1):39-54. doi: 10.2174/1871527322666230301111216.

Tele-Savvy Outcomes of Non-Hispanic Black American and White Caregivers

Bonds Johnson K, Higgins M, Epps F, Brewster GS, Alexander K, Hepburn K.

Gerontologist. 2024 Jan 1;64(1):gnad044. doi: 10.1093/geront/gnad044.

Effects of Alzheimer's Diagnosis and Gender on Ageist Attitudes, Aging Anxiety, and Emotional Reactions to Older Adults

Caskie GIL, Bashian HM, Voelkner AR.

Gerontologist. 2024 Apr 1;64(4):gnad093. doi: 10.1093/geront/gnad093.

Proteinopathy: Shared Feature Between the Heart and Brain in Alzheimer's Disease

Amin G, Booz GW, Zouein FA.

J Cardiovasc Pharmacol. 2024 Jan 1;83(1):4-7. doi: 10.1097/FJC.0000000000001501.

Association of gustatory dysfunction and Alzheimer

Kwak IY, Kim KS, Min HJ.

Rhinology. 2024 Apr 1;62(2):130-142. doi: 10.4193/Rhin23.235.

Paradoxical effects of daytime sleepiness and memory in African Americans at risk for Alzheimer's disease

Lucey BP.

Sleep. 2024 Jan 11;47(1):zsad301. doi: 10.1093/sleep/zsad301.

Noninvasive Gamma Sensory Stimulation May Reduce White Matter and Myelin Loss in Alzheimer's Disease

Da X, Hempel E, Ou Y, Rowe OE, Malchano Z, Hajós M, Kern R, Megerian JT, Cimenser A.

J Alzheimers Dis. 2024;97(1):359-372. doi: 10.3233/JAD-230506.

COVID-19 and Alzheimer's disease: Impact of lockdown and other restrictive measures during the COVID-19 pandemic

Nawaz AD, Haider MZ, Akhtar S.

Biomol Biomed. 2024 Mar 11;24(2):219-229. doi: 10.17305/bb.2023.9680.

Studying the Alzheimer's disease continuum using EEG and fMRI in single-modality and multi-modality settings

Li J, Li X, Chen F, Li W, Chen J, Zhang B.

Rev Neurosci. 2024 Jan 1;35(4):373-386. doi: 10.1515/revneuro-2023-0098. Print 2024 Jun 25.

Alzheimer Disease Treatment With Acetylcholinesterase Inhibitors and Incident Age-Related Macular Degeneration

Sutton SS, Magagnoli J, Cummings TH, Hardin JW, Ambati J.

JAMA Ophthalmol. 2024 Feb 1;142(2):108-114. doi: 10.1001/jamaophthalmol.2023.6014.

Nanotechnology in the diagnostic and therapy for Alzheimer's disease

Panghal A, Flora SJS.

Biochim Biophys Acta Gen Subj. 2024 Mar;1868(3):130559. doi: 10.1016/j.bbagen.2024.130559. Epub 2024 Jan 6.

Changes in dementia treatment patterns associated with changes in the National Policy in South Korea among patients with newly diagnosed Alzheimer's disease between 2011 and 2017: results from the multicenter, retrospective CAPTAIN study

Kim YJ, So KY, Lee HM, Hahn C, Song SH, Lee YS, Kim SW, Park HC, Ryu J, Lee JS, Kang MJ, Kim J, Lee Y, Lee JH.

BMC Public Health. 2024 Jan 12;24(1):168. doi: 10.1186/s12889-024-17671-2.

Single Cell Sequencing Technology and Its Application in Alzheimer's Disease

Han Y, Huang C, Pan Y, Gu X.

J Alzheimers Dis. 2024;97(3):1033-1050. doi: 10.3233/JAD-230861.

Spatiotemporal characteristics of neurophysiological changes in patients with four-repeat tauopathies

Samudra N, Lerner H, Yack L, Walsh CM, Kirsch HE, Kudo K, Yballa C, La Joie R, Gorno-Tempini ML, Spina S, Seeley WW, Neylan TC, Miller BL, Rabinovici GD, Boxer A, Grinberg LT, Rankin KP, Nagarajan SS, Ranasinghe KG.

Ann Clin Transl Neurol. 2024 Feb;11(2):525-535. doi: 10.1002/acn3.51974. Epub 2024 Jan 16.

Burden of Illness in People with Alzheimer's Disease: A Systematic Review of Epidemiology, Comorbidities and Mortality

Lanctôt KL, Hviid Hahn-Pedersen J, Eichinger CS, Freeman C, Clark A, Tarazona LRS, Cummings J.

J Prev Alzheimers Dis. 2024;11(1):97-107. doi: 10.14283/jpad.2023.61.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias